Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
CRAVES FRED B
Director at MADRIGAL PHARMACEUTICALS. Filing since 11 Jun 2018.
CIK 0001014095
Company
Date
Role
Action
Shares
Amount
Of holding
MDGL
MADRIGAL PHARMACEUTICALS, INC.
13 Mar 2025
Director
Sold at will
7,742
$2.52M
2.2%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
12 Mar 2025
Director
Sold at will
7,728
$2.56M
2.2%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
3 Dec 2024
Director
Sold at will
3,600
$1.14M
24.7%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
25 Nov 2024
Director
Sold at will
3,400
$1.19M
18.9%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
14 May 2024
Director
Sold on a plan
22,489
$4.79M
5.2%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
19 Aug 2020
Director
Sold, plan not stated
7,303
$786.09K
14.6%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
18 Aug 2020
Director
Sold, plan not stated
10,197
$1.12M
16.9%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
17 Aug 2020
Director
Sold, plan not stated
12,500
$1.38M
17.2%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
13 Dec 2019
Director
Sold, plan not stated
1,200,000
$126.56M
93.2%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
19 Nov 2018
Director
Bought
2,000
$249.39K
0.7%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
11 Jun 2018
Director
Sold, plan not stated
274,092
$78.79M
4.9%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
11 Jun 2018
Director
Bought
5,908
$1.70M
5.5%
12 decisions on file.
